CRISIL reaffirms AA rating to IPCA Laboratories’ long term bank facilities

30 Aug 2013 Evaluate

Credit rating agency, CRISIL has reaffirmed AA rating to IPCA Laboratories’ long term bank facilities worth Rs 1182.50 crore. The company has received the rating reaffirmation on the back of its well-diversified business risk profile (across therapeutic segments and geographies), established position in the formulations segment both, in domestic and international market, and integrated operations.

IPCA is one of India’s largest suppliers of bulk drugs, such as atenolol (anti-hypertensive), chloroquine and artemisinin derivatives (anti-malarial), furosemide (diuretic), and pyrantel salts (anthelmintic).

 

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×